Fulcrum Shares Plunge Over 50% as FDA Concerns Lead to Scrapping of Key Sickle-Cell Drug
Fulcrum Therapeutics witnessed a significant 52% drop in its share price on Tuesday, following the company’s announcement to halt the
Read MoreFulcrum Therapeutics witnessed a significant 52% drop in its share price on Tuesday, following the company’s announcement to halt the
Read MoreThe Merritronix IPO has shown a current overall subscription rate of 0x, signifying that it has not gained traction within
Read MoreCrude oil futures experienced a decline on Tuesday morning, with August Brent oil prices falling to $94.29, down 0.73%, and
Read MoreIn April 2026, the volume of air freight handled by Indian airports demonstrated resilience amidst the geopolitical crisis in West
Read MoreAnthropic’s AI chatbot Claude faced significant service disruptions on June 2, impacting users across its web platform, mobile application, API
Read MoreIn the current investment landscape, the critical challenge for investors is accurately assessing when a growth story may be nearing
Read MoreThe Liotech Industries IPO has opened its subscription period, commencing on June 1, 2026, and will close on June 3,
Read MoreThe recent performance of the Benchmark Sensex, which surged 382 points to close at 74,649, illustrates a robust uptrend in
Read MorePrism, the parent company of the global travel tech unicorn Oyo, has received approval from the Securities and Exchange Board
Read MoreThe Indian rupee has shown signs of weakness, concluding at 95.2650 per dollar, marking a 0.3% decline from the previous
Read More